Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes

Cellular Immunology

Volumn 272, Issue 1, 2011, Pages 33-38

  Zhou, Changhui ^a,d   Yang, Bo ^b   Tian, Yi ^b   Jiao, Hongliang ^b   Zheng, Wendi ^a   Wang, Jian ^c   Guan, Fangxia ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Immunomodulatory; Interferon ; Lymphocytes; Mesenchymal stem cells; Transforming growth factor 1; Wharton's jelly

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD WHARTON'S JELLY CELL; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; UMBILICAL CORD;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOMODULATION; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MESENCHYMAL STEM CELLS; MICE; PHYTOHEMAGGLUTININS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UMBILICAL CORD; WHARTON JELLY;

EID: 80455160153     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.09.010     Document Type: Article

References (46)

1. Chen M.Y., Lie P.C., Li Z.L., Wei X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp. Hematol. 2009, 37:629-640.
2. Conget P.A., Minguell J.J. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp. Hematol. 2000, 28:382-390.
3. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 2000, 113(7):1161-1166.
4. Lou J., Xu F., Merkel K., Manske P. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res. 1999, 17:43-50.
5. Mbalaviele G., Jaiswal N., Meng A., Cheng L., Van Den Bos C., Thiede M. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 1999, 140:3736-3743.
6. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
7. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 2000, 61:364-370.
8. Mueller S.M., Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J. Cell. Biochem. 2001, 82:583-590.
9. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
10. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
11. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., VanderWerff I., Troyer D., McIntosh K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865-2874.
12. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 2003, 57:11-20.
13. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant. Rev. (Orlando) 2008, 22:262-273.
14. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002, 30:42-48.
15. Yanez R., Lamana M.L., Garcia-Castro J., Colmenero I., Ramirez M., Bueren J.A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem cells 2006, 24:2582-2591.
16. Zhang J., Li Y., Chen J., Cui Y., Lu M., Elias S.B., Mitchell J.B., Hammill L., Vanguri P., Chopp M. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol. 2005, 195:16-26.
17. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., Jorgensen C., Noel D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005, 52:1595-1603.
18. Karussis D., Kassis I., Kurkalli B.G., Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J. Neurol. Sci. 2008, 265:131-135.
19. Magatti M., De Munari S., Vertua E., Gibelli L., Wengler G.S., Parolini O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 2008, 26:182-192.
20. Asari S., Itakura S., Ferreri K., Liu C.P., Kuroda Y., Kandeel F., Mullen Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 2009, 37:604-615.
21. Spaggiari G.M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M.C., Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
22. English K., Barry F.P., Mahon B.P. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol. Lett 2008, 115:50-58.
23. Nasef A., Chapel A., Mazurier C., Bouchet S., Lopez M., Mathieu N., Sensebe L., Zhang Y., Gorin N.C., Thierry D., Fouillard L. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr. 2007, 13:217-226.
24. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
25. Huber S., Schrader J., Fritz G., Presser K., Schmitt S., Waisman A., Luth S., Blessing M., Herkel J., Schramm C. P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg. PLoS ONE 2008, 3:e3302.
26. Zhang B., Liu R., Shi D., Liu X., Chen Y., Dou X., Zhu X., Lu C., Liang W., Liao L., Zenke M., Zhao R.C. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 2009, 113:46-57.
27. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619-4621.
28. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., Edwards C.J., Moss J., Burger J.A., Maini R.N. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000, 2:477-488.
29. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
30. Williams J.T., Southerland S.S., Souza J., Calcutt A.F., Cartledge R.G. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am. Surg. 1999, 65:22-26.
31. Peng H.Q., Levitin-Smith M., Rochelson B., Kahn E. Umbilical cord stricture and overcoiling are common causes of fetal demise. Pediatr. Dev. Pathol. 2006, 9:14-19.
32. Trevisanuto D., Doglioni N., Zanardo V., Chiarelli S. Overcoiling of the umbilical cord. J. Pediatr. 2007, 150:112.
33. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005, 23:220-229.
34. Karahuseyinoglu S., Cinar O., Kilic E., Kara F., Akay G.G., Demiralp D.O., Tukun A., Uckan D., Can A. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007, 25:319-331.
35. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., Fu Y.S., Lai M.C., Chen C.C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22:1330-1337.
36. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., Luo Y., Rao M.S., Velagaleti G., Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
37. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 2006, 24:115-124.
38. Lund R.D., Wang S., Lu B., Girman S., Holmes T., Sauve Y., Messina D.J., Harris I.R., Kihm A.J., Harmon A.M., Chin F.Y., Gosiewska A., Mistry S.K. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007, 25:602-611.
39. Jomura S., Uy M., Mitchell K., Dallasen R., Bode C.J., Xu Y. Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells. Stem Cells 2007, 25:98-106.
40. Rachakatla R.S., Marini F., Weiss M.L., Tamura M., Troyer D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 2007, 14:828-835.
41. Wang M., Yang Y., Yang D., Luo F., Liang W., Guo S., Xu J. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009, 126:220-232.
42. Medicetty S., Bledsoe A.R., Fahrenholtz C.B., Troyer D., Weiss M.L. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Exp. Neurol. 2004, 190:32-41.
43. Bian L., Guo Z.K., Wang H.X., Wang J.S., Wang H., Li Q.F., Yang Y.F., Xiao F.J., Wu C.T., Wang L.S. In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In vivo 2009, 23:21-27.
44. Bommireddy R., Saxena V., Ormsby I., Yin M., Boivin G.P., Babcock G.F., Singh R.R., Doetschman T. TGF-beta 1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J. Immunol. 2003, 170:4612-4622.
45. Xu G., Zhang Y., Zhang L., Ren G., Shi Y. The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2007, 361:745-750.
46. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.